Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ADVANCED ENZYME TECHNOLOGIES vs SAKAR HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ADVANCED ENZYME TECHNOLOGIES SAKAR HEALTHCARE ADVANCED ENZYME TECHNOLOGIES/
SAKAR HEALTHCARE
 
P/E (TTM) x 29.2 50.4 58.0% View Chart
P/BV x 3.1 2.4 128.2% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 ADVANCED ENZYME TECHNOLOGIES   SAKAR HEALTHCARE
EQUITY SHARE DATA
    ADVANCED ENZYME TECHNOLOGIES
Mar-24
SAKAR HEALTHCARE
Mar-24
ADVANCED ENZYME TECHNOLOGIES/
SAKAR HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs425479 88.7%   
Low Rs233197 118.2%   
Sales per share (Unadj.) Rs55.870.5 79.1%  
Earnings per share (Unadj.) Rs12.25.4 228.2%  
Cash flow per share (Unadj.) Rs15.413.7 112.7%  
Dividends per share (Unadj.) Rs5.100-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs118.1118.4 99.8%  
Shares outstanding (eoy) m111.8221.75 514.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.94.8 123.0%   
Avg P/E ratio x26.963.0 42.7%  
P/CF ratio (eoy) x21.424.7 86.4%  
Price / Book Value ratio x2.82.9 97.6%  
Dividend payout %41.60-   
Avg Mkt Cap Rs m36,7937,351 500.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,284188 681.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,2391,534 406.8%  
Other income Rs m37032 1,163.8%   
Total revenues Rs m6,6081,565 422.2%   
Gross profit Rs m1,902384 495.5%  
Depreciation Rs m352181 195.2%   
Interest Rs m4176 54.1%   
Profit before tax Rs m1,878159 1,181.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m50942 1,202.9%   
Profit after tax Rs m1,370117 1,173.4%  
Gross profit margin %30.525.0 121.8%  
Effective tax rate %27.126.6 101.8%   
Net profit margin %22.07.6 288.4%  
BALANCE SHEET DATA
Current assets Rs m8,097716 1,130.7%   
Current liabilities Rs m1,064591 180.1%   
Net working cap to sales %112.78.2 1,377.4%  
Current ratio x7.61.2 627.9%  
Inventory Days Days2486 4,259.2%  
Debtors Days Days58498 11.6%  
Net fixed assets Rs m7,1143,170 224.4%   
Share capital Rs m224218 102.8%   
"Free" reserves Rs m12,9872,358 550.8%   
Net worth Rs m13,2112,575 513.0%   
Long term debt Rs m70550 12.7%   
Total assets Rs m15,2123,887 391.4%  
Interest coverage x46.63.1 1,508.4%   
Debt to equity ratio x00.2 2.5%  
Sales to assets ratio x0.40.4 103.9%   
Return on assets %9.35.0 186.9%  
Return on equity %10.44.5 228.7%  
Return on capital %14.57.5 192.1%  
Exports to sales %17.665.1 27.0%   
Imports to sales %9.50-   
Exports (fob) Rs m1,097998 109.8%   
Imports (cif) Rs m594NA-   
Fx inflow Rs m1,097998 109.8%   
Fx outflow Rs m594258 230.4%   
Net fx Rs m502740 67.8%   
CASH FLOW
From Operations Rs m1,414245 577.8%  
From Investments Rs m-646-515 125.4%  
From Financial Activity Rs m-592274 -215.8%  
Net Cashflow Rs m1734 4,658.9%  

Share Holding

Indian Promoters % 2.0 53.2 3.7%  
Foreign collaborators % 41.0 0.0 -  
Indian inst/Mut Fund % 20.7 24.0 85.9%  
FIIs % 12.6 13.4 94.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 46.9 121.8%  
Shareholders   66,758 7,867 848.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ADVANCED ENZYME TECHNOLOGIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ADVANCED ENZYME TECHNOLOGIES vs SAKAR HEALTHCARE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ADVANCED ENZYME TECHNOLOGIES vs SAKAR HEALTHCARE Share Price Performance

Period ADVANCED ENZYME TECHNOLOGIES SAKAR HEALTHCARE S&P BSE HEALTHCARE
1-Day 0.29% 0.44% 0.63%
1-Month -15.77% -4.85% 0.94%
1-Year 10.59% -26.31% 45.81%
3-Year CAGR 3.18% 25.99% 19.52%
5-Year CAGR 16.81% 40.97% 26.05%

* Compound Annual Growth Rate

Here are more details on the ADVANCED ENZYME TECHNOLOGIES share price and the SAKAR HEALTHCARE share price.

Moving on to shareholding structures...

The promoters of ADVANCED ENZYME TECHNOLOGIES hold a 43.0% stake in the company. In case of SAKAR HEALTHCARE the stake stands at 53.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES and the shareholding pattern of SAKAR HEALTHCARE .

Finally, a word on dividends...

In the most recent financial year, ADVANCED ENZYME TECHNOLOGIES paid a dividend of Rs 5.1 per share. This amounted to a Dividend Payout ratio of 41.6%.

SAKAR HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ADVANCED ENZYME TECHNOLOGIES, and the dividend history of SAKAR HEALTHCARE .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.